Autologous haematopoietic stem cell transplantation as a first-line disease-modifying therapy in patients with ‘aggressive’ multiple sclerosis

BACKGROUND: Autologous haematopoietic stem cell transplantation (AHSCT) is an effective treatment for patients with multiple sclerosis (MS) who have highly active disease, despite the use of standard disease-modifying therapies (DMTs). However, the optimal time for offering AHSCT to patients with ‘a...

Descripción completa

Detalles Bibliográficos
Autores principales: Das, J, Snowden, JA, Burman, J, Freedman, MS, Atkins, H, Bowman, M, Burt, RK, Saccardi, R, Innocenti, C, Mistry, S, Laud, PJ, Jessop, H, Sharrack, B
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Original Research Papers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8226372/
https://www.ncbi.nlm.nih.gov/pubmed/33565902
http://dx.doi.org/10.1177/1352458520985238

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8226372/
https://www.ncbi.nlm.nih.gov/pubmed/33565902
http://dx.doi.org/10.1177/1352458520985238

Ejemplares similares